These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 228697)
1. Selective deficiency of hepatic triglyceride lipase and hypertriglyceridaemia in kwashiorkor. Agbedana EO; Johnson AO; Taylor GO Br J Nutr; 1979 Nov; 42(3):351-6. PubMed ID: 228697 [TBL] [Abstract][Full Text] [Related]
2. Studies on hepatic and extrahepatic lipoprotein lipases in protein-calorie malnutrition. Agbedana EO; Johnson AO; Taylor GO Am J Clin Nutr; 1979 Feb; 32(2):292-8. PubMed ID: 105620 [TBL] [Abstract][Full Text] [Related]
3. Ex vivo measurement of lipoprotein lipase-dependent very low density lipoprotein (VLDL)-triglyceride hydrolysis in human VLDL: an alternative to the postheparin assay of lipoprotein lipase activity? Pruneta V; Autran D; Ponsin G; Marcais C; Duvillard L; Verges B; Berthezene F; Moulin P J Clin Endocrinol Metab; 2001 Feb; 86(2):797-803. PubMed ID: 11158049 [TBL] [Abstract][Full Text] [Related]
4. Dietary effects in the early recovery phase of kwashiorkor. Plasma levels of triglycerides, FFA, D-beta-hydroxybutyrate, glycerol, postheparin lipoprotein lipase (LPL), glucose and insulin. Persson B; Habte D; Sterky G Acta Paediatr Scand; 1976 May; 65(3):329-36. PubMed ID: 1274567 [TBL] [Abstract][Full Text] [Related]
5. Transport kinetics of plasma free fatty acid, very low density lipoprotein triglycerides and apoprotein in patients with endogenous hypertriglyceridaemia: effects of 2,2-dimethyl, 5(2, 5-xylyoxy) valeric acid therapy. Kissebah AH; Alfarsi S; Adams PW; Seed M; Folkard J; Wynn V Atherosclerosis; 1976; 24(1-2):199-218. PubMed ID: 182185 [TBL] [Abstract][Full Text] [Related]
6. Gemfibrozil: effect on serum lipids, lipoproteins, postheparin plasma lipase activities and glucose tolerance in primary hypertriglyceridaemia. Nikkilä EA; Ylikahri R; Huttunen JK Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):58-63. PubMed ID: 190608 [TBL] [Abstract][Full Text] [Related]
7. [Diurnal changes in postheparin lipolytic activity (PHLA) and the role of PHLA in triglyceride catabolism in young and middle-aged obese individuals]. Watanabe T Nihon Ronen Igakkai Zasshi; 1991 Sep; 28(5):646-56. PubMed ID: 1753427 [TBL] [Abstract][Full Text] [Related]
9. Reversible abnormalities in postheparin lipolytic activity during the late phase of release in diabetes mellitus (postheparin lipolytic activity in diabetes). Brunzell JD; Porte D; Bierman EL Metabolism; 1975 Oct; 24(10):1123-37. PubMed ID: 1165728 [TBL] [Abstract][Full Text] [Related]
10. Free fatty acid metabolism during fenofibrate treatment of the metabolic syndrome. Vega GL; Cater NB; Hadizadeh DR; Meguro S; Grundy SM Clin Pharmacol Ther; 2003 Sep; 74(3):236-44. PubMed ID: 12966367 [TBL] [Abstract][Full Text] [Related]
11. Selective deficiency of hepatic triglyceride lipase in uremic patients. Mordasini R; Frey F; Flury W; Klose G; Greten H N Engl J Med; 1977 Dec; 297(25):1362-6. PubMed ID: 200841 [TBL] [Abstract][Full Text] [Related]
12. Postheparin plasma lipoprotein lipase and hepatic lipase in diabetes mellitus. Relationship to plasma triglyceride metabolism. Nikkilä EA; Huttunen JK; Ehnholm C Diabetes; 1977 Jan; 26(1):11-21. PubMed ID: 187516 [TBL] [Abstract][Full Text] [Related]
13. Role of lipoprotein lipase activity on lipoprotein metabolism and the fate of circulating triglycerides in pregnancy. Herrera E; Lasunción MA; Gomez-Coronado D; Aranda P; López-Luna P; Maier I Am J Obstet Gynecol; 1988 Jun; 158(6 Pt 2):1575-83. PubMed ID: 3287929 [TBL] [Abstract][Full Text] [Related]
15. Effect of heparin-induced lipolysis on the distribution of apolipoprotein e among lipoprotein subclasses. Studies with patients deficient in hepatic triglyceride lipase and lipoprotein lipase. Rubinstein A; Gibson JC; Paterniti JR; Kakis G; Little A; Ginsberg HN; Brown WV J Clin Invest; 1985 Feb; 75(2):710-21. PubMed ID: 3973025 [TBL] [Abstract][Full Text] [Related]
16. VLDL triglyceride kinetics in Wistar fatty rats, an animal model of NIDDM: effects of dietary fructose alone or in combination with pioglitazone. Kazumi T; Hirano T; Odaka H; Ebara T; Amano N; Hozumi T; Ishida Y; Yoshino G Diabetes; 1996 Jun; 45(6):806-11. PubMed ID: 8635657 [TBL] [Abstract][Full Text] [Related]